Detalhe da pesquisa
1.
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma.
J Clin Oncol
; : JCO2301684, 2024 Apr 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38684039
2.
Pharmacokinetics of Dacarbazine and Unesbulin and CYP1A2-Mediated Drug Interactions in Patients With Leiomyosarcoma.
Clin Transl Sci
; 2023 Dec 21.
Artigo
Inglês
| MEDLINE | ID: mdl-38129988
3.
Exceptional Response to Dacarbazine in Uterine Leiomyosarcoma With Homozygous BRCA2 Deletion Highlights the Role of Homologous Recombination in Response to DNA Damage From Alkylating Agents.
JCO Precis Oncol
; 2: 1-6, 2018 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-35135137